{
    "eid": "2-s2.0-85152649197",
    "title": "Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "breast cancer",
        "dysbiosis",
        "estrogen",
        "gut microbiome",
        "microbial diversity"
    ],
    "authors": [
        "May Soe Thu",
        "Korn Chotirosniramit",
        "Tanawin Nopsopon",
        "Nattiya Hirankarn",
        "Krit Pongpirul"
    ],
    "citedby-count": 1,
    "ref-count": 74,
    "ref-list": [
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Breast cancer",
        "Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol",
        "Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects",
        "Hereditary breast cancer: ever more pieces to the polygenic puzzle",
        "Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study",
        "Relationship between gut microbiota and host-metabolism: Emphasis on hormones related to reproductive function",
        "Current understanding of the human microbiome",
        "Could lung bacterial dysbiosis predict ICU mortality in patients with extra-pulmonary sepsis? A proof-of-concept study",
        "Dysbiosis of the gut microbiome in lung cancer",
        "An Oxford nanopore-based characterisation of sputum microbiota dysbiosis in patients with tuberculosis: from baseline to 7 days after antibiotic treatment",
        "Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment",
        "Microbiota of human breast tissue",
        "Distinct microbial signatures associated with different breast cancer types",
        "Breast cancer in postmenopausal women is associated with an altered gut metagenome",
        "Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer",
        "Breast tissue, oral and urinary microbiomes in breast cancer",
        "A comprehensive analysis of breast cancer microbiota and host gene expression",
        "Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females",
        "Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors",
        "Metabolomics-microbiome crosstalk in the breast cancer microenvironment",
        "Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar, but unexplored",
        "The role of gut microbial beta-glucuronidase in estrogen reactivation and breast cancer",
        "Role of microbiota-derived short-chain fatty acids in cancer development and prevention",
        "The role of bile acids in carcinogenesis",
        "The gut microbiome: Relationships with disease and opportunities for therapy",
        "Gut microbiota response to antibiotics is personalized and depends on baseline microbiota",
        "Role of microbiome in modulating immune responses in cancer",
        "Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment",
        "Exploring the potential of breast microbiota as biomarker for breast cancer and therapeutic response",
        "Prognostic correlations with the microbiome of breast cancer subtypes",
        "Escherichia coli induces DNA double-strand breaks in eukaryotic cells",
        "Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin/beta-catenin signaling via its FadA adhesin",
        "Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with helicobacter felis infection",
        "PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews",
        "Evaluation of PICO as a knowledge representation for clinical questions",
        "Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes",
        "ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions",
        "Chapter 8: Assessing risk of bias in included studies",
        "Intestinal microflora as an alternative metabolic source of estrogens in women with uterine leiomyoma and breast cancer",
        "Intestinal ecosystem and metabolic capacity in women with breast cancer",
        "Microbial dysbiosis is associated with human breast cancer",
        "Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study",
        "Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota",
        "Distinct microbiological signatures associated with triple negative breast cancer",
        "The microbiota of breast tissue and its association with breast cancer",
        "The microbiome of aseptically collected human breast tissue in benign and malignant disease",
        "Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic black and non-Hispanic white women",
        "Alter between gut bacteria and blood metabolites and the anti-tumor effects of faecalibacterium prausnitzii in breast cancer",
        "Microbiota composition in bilateral healthy breast tissue and breast tumors",
        "The intestinal microbiome, weight, and metabolic changes in women treated by adjuvant chemotherapy for breast and gynecological malignancies",
        "Changes of intestinal microflora of breast cancer in premenopausal women",
        "Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana breast health study",
        "Intestinal proportion of blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer",
        "Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy",
        "Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions",
        "Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer",
        "Physiologic intestinal (18)F-FDG uptake is associated with alteration of gut microbiota and proinflammatory cytokine levels in breast cancer",
        "Comparative analysis of racial differences in breast tumor microbiome",
        "Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer",
        "Relationships of sleep disturbance, intestinal microbiota, and postoperative pain in breast cancer patients: a prospective observational study",
        "Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study",
        "Fecal akkermansia muciniphila is associated with body composition and microbiota diversity in overweight and obese women with breast cancer participating in a presurgical weight loss trial",
        "Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis",
        "Gut microbiome associations with breast cancer risk factors and tumor characteristics: A pilot study",
        "Gut microbiota profiling in patients with HER2-negative metastatic breast cancer receiving metronomic chemotherapy of capecitabine compared to those under conventional dosage",
        "A review on measurement of alpha diversity in biology",
        "A human gut microbial gene catalogue established by metagenomic sequencing",
        "Gut microbiota, metabolic disorders and breast cancer: Could berberine turn out to be a transversal nutraceutical tool? A narrative analysis",
        "Microbiota effects on cancer: from risks to therapies",
        "The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies",
        "Spotlight on the gut microbiome in menopause: Current insights",
        "Precocious puberty and microbiota: The role of the sex hormone-gut microbiome axis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}